gvtcx

PHE_Scientific Provision to purchase Quantstudio7-Genotyping/genomic expansion

Public Health England Published 10 May 2021 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£400,000
Statuscomplete
Category (CPV) 38950000 +1 more
Deadline29 Apr 2021
Contract start30 Apr 2021
Contract end29 Apr 2022
Procedureselective
SME suitableYes
OCIDocds-b5fd17-6155b56e-0ad1-4b28-bb7c-1e406bd76e25

Award

SupplierValueDateStatus
Life Technologies Limited £400,000 29 Apr 2021 active

description

PHE has awarded a contract to Life Technologies Ltd ( Thermo Fisher Scientific) Under the PHE Microbiology Framework -Lot 2 for the provision of purchase of Quantstudio 7 Flex platforms to provide additional capacity capability to test SARS Cov 2 variant within the existing workflow to ensure compatibility.

The is a PHE wide one year contract.

The initial purchase is for GBP274812.91 Ex VAT,additional equipment can be purchased provided that the total value of the contract is no more than GBP 400,000 (ex. VAT)

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
10 May 2021 Award (award) · c316c51c-fdbd-487c-ae46-a51b7ebf60b4-435004

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.